淡紫色花
发表于 2025-3-30 08:40:02
http://reply.papertrans.cn/39/3809/380870/380870_51.png
独裁政府
发表于 2025-3-30 14:15:17
http://reply.papertrans.cn/39/3809/380870/380870_52.png
阻止
发表于 2025-3-30 19:18:13
http://reply.papertrans.cn/39/3809/380870/380870_53.png
Melatonin
发表于 2025-3-30 23:08:13
http://reply.papertrans.cn/39/3809/380870/380870_54.png
温顺
发表于 2025-3-31 02:17:17
http://reply.papertrans.cn/39/3809/380870/380870_55.png
inhumane
发表于 2025-3-31 06:48:53
Importance of Adequate Lymphadenectomy in Gastrointestinal Cancer,emains controversial, adequate lymph node examination is required for accurate staging such that patients can receive correct adjuvant treatments and for stratification in clinical trials. Nevertheless, wide variation in the quality of lymph node examination exists in the US and many centers are not meeting guideline treatment recommendations.
Macronutrients
发表于 2025-3-31 11:06:38
http://reply.papertrans.cn/39/3809/380870/380870_57.png
headlong
发表于 2025-3-31 13:37:01
https://doi.org/10.1007/978-3-642-59288-1This chapter explores the pathologic features of benign and malignant lesions of the pancreas. As pathologic classifications evolve, particularly for cystic lesions and neuroendocrine tumors, it is important for physicians who treat patients with pancreatic neoplasms to fully evaluate these pathologic classifications.
恶名声
发表于 2025-3-31 17:46:25
Management Controversies and Treatment Strategies for Borderline Resectable Pancreatic Cancer,The management of borderline resectable cancer requires multi-disciplinary care including state-of-the-art radiographic imaging, combination treatment planning with medical oncology and radiation oncology, and technical surgical expertise combining gastrointestinal and vascular surgery.
无表情
发表于 2025-4-1 01:22:55
Pathologic Features of Primary Pancreatic Malignancies,This chapter explores the pathologic features of benign and malignant lesions of the pancreas. As pathologic classifications evolve, particularly for cystic lesions and neuroendocrine tumors, it is important for physicians who treat patients with pancreatic neoplasms to fully evaluate these pathologic classifications.